| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/22/2006 | CN1736443A Chinese medicinal ointment for treating pneumonia |
| 02/22/2006 | CN1736438A Medicine for treating hepatitis B |
| 02/22/2006 | CN1736437A Medicinal composition for treating dermatosis |
| 02/22/2006 | CN1736423A Method for preparing externally applied medicine for feet tinea |
| 02/22/2006 | CN1736404A Compound preparation with isatis root and Vitamin C |
| 02/22/2006 | CN1736394A An anti-AIDS injection and preparation process thereof |
| 02/22/2006 | CN1736393A An anit-AIDS material drug, formulation and preparation process thereof |
| 02/22/2006 | CN1736392A Injection with adetphos and magnesium chloride and preparation process thereof |
| 02/22/2006 | CN1736382A Compound chlorpromazine |
| 02/22/2006 | CN1736379A Moxifloxaci gelatin capsule and preparation process thereof |
| 02/22/2006 | CN1243103C Preparation process of burduck protoglucoside of anti virus and antiptmour natural medicine |
| 02/22/2006 | CN1243100C Method for production of cytosporasp B and the use in preparation of anti-tumor and antifungal medicine |
| 02/22/2006 | CN1243093C Using phenylethyl caffeiate derivative, capsaicin and resin toxin to inhibit NF-KB |
| 02/22/2006 | CN1243000C Tocopherols, tocotrienols, other chroman and side chain dervative and uses thereof |
| 02/22/2006 | CN1242797C Compound barbiers liquid |
| 02/22/2006 | CN1242771C Traditional Chinese medicine for treating virus hepatitis and preparation process thereof |
| 02/22/2006 | CN1242768C Hepatitis treating medicine and its preparing process |
| 02/22/2006 | CN1242758C Filmy lagging cover tablet for treating cold |
| 02/22/2006 | CN1242755C Chinese traditional medicine extracts and its preparation and application in pharmacy |
| 02/22/2006 | CN1242754C Chinese traditional medicine for upper respiratory tract infection |
| 02/22/2006 | CN1242750C Biodegradable and biocompatible polymeric microsphores encapsulating salmonella enteritidis bacteria |
| 02/22/2006 | CN1242743C Method for preparing Penciclovir gelling agent |
| 02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
| 02/21/2006 | US7001983 Non-hemolytic cytolytic peptides;antibacterial, anticancer, antiprotozoal agents |
| 02/21/2006 | US7001913 substituted naphthyridine aminopiperidines; bacterial infections |
| 02/21/2006 | US7001912 Beta-carboline hydroxamic acid substituted pyrido 3,4-B indole compounds; 9-(4-fluorobenzyl)-N-hydroxy-9H- beta -carboline-3-carboxamide |
| 02/21/2006 | US7001910 substituted pyrimidinyl-amino-ethoxy benzyl-thiazolidine-diones; hypoglycemic agents |
| 02/21/2006 | US7001897 Such as (1R,5S,6S)-2-(1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl)thio-6-((1R)-1 -hydroxyethyl)-1-methylcarbapen -2-em-3-carboxylic acid for treatment/prevention of bacterial infections |
| 02/21/2006 | US7001760 Hepatitis B virus vectors for gene therapy |
| 02/21/2006 | US7001744 Gene encoding an antigenic determinant of Escherichia coli is connected to a nontoxic cholera toxin A2 and B subunits (CTXA2B) gene of Vibrio cholerae; chimeric protein is useful as oral vaccine against uropathogenic E. coli with mild side effects |
| 02/21/2006 | US7001734 Process for identifying para cation channel modulators |
| 02/21/2006 | US7001718 Prevent complexing of Dna and ligand; viricides; drug mixture with carrier |
| 02/21/2006 | US7001595 For therapy of rheumatoid arthritis, inflammation, respiratory diseases, allergy |
| 02/21/2006 | CA2453080C Polyene polyketides, processes for their production and their use as a pharmaceutical |
| 02/21/2006 | CA2395196C Cyclic amp-specific phosphodiesterase inhibitors |
| 02/21/2006 | CA2356306C Sulfated phosphatidylinositols, their preparation and use |
| 02/21/2006 | CA2337846C Polymorph of ritonavir |
| 02/21/2006 | CA2267309C Use of 1-hydroxy-2-pyridones for the treatment of skin infections |
| 02/21/2006 | CA2091181C Cloning of chicken anaemia dna |
| 02/21/2006 | CA2032381C Viral agent |
| 02/16/2006 | WO2006016657A1 Drug for treating or preventing hcv infection |
| 02/16/2006 | WO2006016582A1 Liquid culture method for inonotus obliquns |
| 02/16/2006 | WO2006015886A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | WO2005121160A3 11, 12 cyclic thiocarbamate macrolide antibacterial agents |
| 02/16/2006 | WO2005062748A3 Bicyclic carbohydrate compounds useful in the treatment of infections caused by herpesviridae |
| 02/16/2006 | WO2004071430A3 RNAi TARGETING OF VIRUSES |
| 02/16/2006 | WO2004024095A3 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 02/16/2006 | WO2003083058A3 Replikin peptides in rapid replication of glioma cells and in influenza epidemics |
| 02/16/2006 | WO2003033720A8 Protein based tnf-alpha variants for the treatment of tnf-alpha related disorders |
| 02/16/2006 | US20060036089 33 human secreted proteins |
| 02/16/2006 | US20060035979 Inhibitors of transcription factor NF-kappaB |
| 02/16/2006 | US20060035909 2,6,9-trisubstituted 8-azapurines such as 2-(4-aminocyclohexylamino)-6-benzylamino-9-isopropyl-8-azapurine, used as cyclin-dependent kinase inhibitors, in the treatment of skin disorders, viral infections, cancer, arthritis, lupus, diabetes, multiple sclerosis, restenosis, polycystic kidney disease, gout |
| 02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
| 02/16/2006 | US20060035895 Isoxazoline derivatives useful as antimicrobials |
| 02/16/2006 | US20060035870 Carboxylic acid derivatives as IP antagonists |
| 02/16/2006 | US20060035856 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035855 Purified polypeptides having IL-13 receptor activity |
| 02/16/2006 | US20060035842 Ophthalmic composition |
| 02/16/2006 | US20060035839 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 02/16/2006 | US20060035820 Fungicides trans 1-[4-[(2-aminocyclo-hexyl)-amino]N2-[[4''(pentyloxy)[1,1':4', 1''-terphenyl]-4-yl-carbonyl]-L-ornithine]-4-[4(4-hydroxyphenyl)-L-threonine]-5-L-serine-echinocandine B trifluoroacetate; treating infections caused by Candida, Aspergillus, Cryptococcus |
| 02/16/2006 | US20060035331 G-protein coupled receptors |
| 02/16/2006 | US20060035315 Transporters and ion channels |
| 02/16/2006 | US20060035293 Antibodies, polypeptides and polynucleotides, used for detection, prevention and treatment of diseases caused by gramnegative bacteria |
| 02/16/2006 | US20060035284 Methods for isolating molecular mimetics of unique Neisseria meningitidis serogroup B epitopes |
| 02/16/2006 | US20060035260 Nucleotide sequences derived from the genome of retroviruses of the HIV-1, HIV-2 and SIV type, and their uses in particular for the amplification of the genomes of these retroviruses and for the in vitro diagnosis of the diseases due to these viruses |
| 02/16/2006 | US20060035221 Use of the glycine n-acyl transferase (gnat) for the diagnosis and therapy of inflammatory diseases and sepsis |
| 02/16/2006 | US20060035213 POSH nucleic acids, polypeptides and related methods |
| 02/16/2006 | US20060035212 Molecules inhibiting hepatitis c virus protein synthesis and method for screening same |
| 02/16/2006 | US20060034951 Active fraction having anti-cancer and anti-metastasis isolated from leaves and stems of ginseng |
| 02/16/2006 | US20060034917 Coating of tablet cores |
| 02/16/2006 | US20060034892 Composition for topical administration |
| 02/16/2006 | US20060034868 Veterinary medicine; respiratory system disorders; inoculating with attenuation virus |
| 02/16/2006 | US20060034863 Compositions useful as ligands for the formyl peptide receptor like 1 receptor and methods of use thereof |
| 02/16/2006 | US20060034861 HCV E1 comprising specific disulfide bridges |
| 02/16/2006 | US20060034817 Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyase |
| 02/16/2006 | US20060034798 Water-in-oil emulsions with ethylene oxide groups, compositions, and methods |
| 02/16/2006 | DE29924843U1 Pellet for treating fungal infection comprises core coated with film of water soluble polymer and antifungal agent |
| 02/16/2006 | DE102004035203A1 Substituierte Chinolone Substituted Quinolones |
| 02/16/2006 | CA2576949A1 Pyrazolo[1,5-a]pyrimidine derivatives |
| 02/16/2006 | CA2576627A1 Angiogenic and immunologic applications of anti-cd160 specific compounds obtainable from mab cl1-r2 |
| 02/16/2006 | CA2576041A1 Oxazolidinones containing oxindoles as antibacterial agents |
| 02/16/2006 | CA2575932A1 Pharmaceutical formulations comprising pleconaril for the treatment of airway diseases |
| 02/16/2006 | CA2575702A1 Oxindole oxazolidinones as antibacterial agents |
| 02/16/2006 | CA2575002A1 Hiv inhibiting 1,2,4-triazin-6-one derivatives |
| 02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 02/15/2006 | EP1626059A1 Angiogenic and immunologic applications of anti-CD160 specific compounds obtainable from mAb CL1-R2 |
| 02/15/2006 | EP1626051A1 Crystals of quinolinecarboxylic acid derivative solvate |
| 02/15/2006 | EP1625852A1 Chimeric flavivirus vaccines |
| 02/15/2006 | EP1625851A1 Preparation for preventing contact of pathogenic matter with living organism |
| 02/15/2006 | EP1625847A1 Pharmaceutical composition comprising a tetrahydrotriazolo[4,3-a]pyrazine |
| 02/15/2006 | EP1625149A2 Method and carrier complexes for delivering molecules to cells |
| 02/15/2006 | EP1625130A2 Hiv integrase inhibitors |
| 02/15/2006 | EP1625129A1 Heterocyclyl-substituted dihydroquinazolines and use thereof as an antiviral agent |
| 02/15/2006 | EP1625124A1 Oxazolidinone derivatives as antimicrobials |
| 02/15/2006 | EP1624886A2 Methods for increasing cell and tissue viability |
| 02/15/2006 | EP0871738B1 Viral recombinant pseudo-particles and vaccinal and anti-tumoral applications |
| 02/15/2006 | EP0762892B1 Diphtheria toxin vaccines bearing a mutated r domain |
| 02/15/2006 | CN1735630A Therapeutic polypeptides, homologues thereof, fragments thereof and for use in modulating platelet-mediated aggregation |
| 02/15/2006 | CN1735628A Polypeptides F' of the hepatitis c virus, epitopes, and the diagnostic and therapeutic applications thereof |
| 02/15/2006 | CN1735612A Anti-infective agents |